Bladder cancer: Clinical practice guidelines in oncology

Peter E. Clark; Neeraj Agarwal; Matthew C. Biagioli; Mario A. Eisenberger; Richard E. Greenberg; Harry W. Herr; Brant A. Inman; Deborah A. Kuban; Timothy M. Kuzel; Subodh M. Lele; Jeff Michalski; Lance C. Pagliaro; Sumanta K. Pal; Anthony Patterson; Elizabeth R. Plimack; Kamal S. Pohar; Michael P. Porter; Jerome P. Richie; Wade J. Sexton; William U. Shipley; Eric J. Small; Philippe E. Spiess; Donald L. Trump; Geoffrey Wile; Timothy G. Wilson; Mary Dwyer; Maria Ho

doi:10.6004/jnccn.2013.0059

Bladder cancer: Clinical practice guidelines in oncology

Peter E. Clark
, Neeraj Agarwal
, Matthew C. Biagioli
, Mario A. Eisenberger
, Richard E. Greenberg
, Harry W. Herr
, Brant A. Inman
, Deborah A. Kuban
, Timothy M. Kuzel
, Subodh M. Lele
, Jeff Michalski
, Lance C. Pagliaro
, Sumanta K. Pal
, Anthony Patterson
, Elizabeth R. Plimack
, Kamal S. Pohar
, Michael P. Porter
, Jerome P. Richie
, Wade J. Sexton
, William U. Shipley

Eric J. Small, Philippe E. Spiess, Donald L. Trump, Geoffrey Wile, Timothy G. Wilson, Mary Dwyer, Maria Ho

Vanderbilt University
University of Utah
Johns Hopkins University
Fox Chase Cancer Center
Memorial Sloan-Kettering Cancer Center
Duke University
Northwestern University
Nebraska Medicine
Washington University St. Louis
University of Tennessee Health Science Center
Ohio State University
Seattle Cancer Care Alliance
Dana-Farber Cancer Institute
University of South Florida
Massachusetts General Hospital Cancer Center
University of California at San Francisco
Roswell Park Cancer Institute

Research output: Contribution to journal › Article › peer-review

325 Scopus citations

Abstract

Bladder cancer is the fourth most common cancer in the United States. Urothelial carcinoma that originates from the urinary bladder is the most common subtype. These NCCN Clinical Practice Guidelines in Oncology (NCCN Guidelines) provide recommendations on the diagnosis and management of non-muscle-invasive and muscle-invasive urothelial carcinoma of the bladder. This version of the guidelines provides extensive reorganization and updates on the principles of chemotherapy management.

Original language	English
Pages (from-to)	446-475
Number of pages	30
Journal	Journal of the National Comprehensive Cancer Network : JNCCN
Volume	11
Issue number	4
DOIs	https://doi.org/10.6004/jnccn.2013.0059
State	Published - Apr 1 2013

UN SDGs

This output contributes to the following UN Sustainable Development Goals (SDGs)

SDG 3 Good Health and Well-being

Keywords

Administration, Intravesical
Algorithms
Antineoplastic Combined Chemotherapy Protocols/therapeutic use
Carcinoma/drug therapy
Cystectomy/methods
Female
Humans
Male
Muscle Neoplasms/drug therapy
Neoadjuvant Therapy/methods
Neoplasm Invasiveness
Neoplasm Staging/methods
Organ Sparing Treatments/methods
Urinary Bladder Neoplasms/drug therapy
Urothelium/pathology

Access to Document

10.6004/jnccn.2013.0059

Cite this

Clark, P. E., Agarwal, N., Biagioli, M. C., Eisenberger, M. A., Greenberg, R. E., Herr, H. W., Inman, B. A., Kuban, D. A., Kuzel, T. M., Lele, S. M., Michalski, J., Pagliaro, L. C., Pal, S. K., Patterson, A., Plimack, E. R., Pohar, K. S., Porter, M. P., Richie, J. P., Sexton, W. J., ... Ho, M. (2013). Bladder cancer: Clinical practice guidelines in oncology. Journal of the National Comprehensive Cancer Network : JNCCN, 11(4), 446-475. https://doi.org/10.6004/jnccn.2013.0059

@article{cd10050e644b4829ad78bb70a1bc0ad5,

title = "Bladder cancer: Clinical practice guidelines in oncology",

abstract = "Bladder cancer is the fourth most common cancer in the United States. Urothelial carcinoma that originates from the urinary bladder is the most common subtype. These NCCN Clinical Practice Guidelines in Oncology (NCCN Guidelines) provide recommendations on the diagnosis and management of non-muscle-invasive and muscle-invasive urothelial carcinoma of the bladder. This version of the guidelines provides extensive reorganization and updates on the principles of chemotherapy management.",

keywords = "Administration, Intravesical, Algorithms, Antineoplastic Combined Chemotherapy Protocols/therapeutic use, Carcinoma/drug therapy, Cystectomy/methods, Female, Humans, Male, Muscle Neoplasms/drug therapy, Neoadjuvant Therapy/methods, Neoplasm Invasiveness, Neoplasm Staging/methods, Organ Sparing Treatments/methods, Urinary Bladder Neoplasms/drug therapy, Urothelium/pathology",

author = "Clark, \{Peter E.\} and Neeraj Agarwal and Biagioli, \{Matthew C.\} and Eisenberger, \{Mario A.\} and Greenberg, \{Richard E.\} and Herr, \{Harry W.\} and Inman, \{Brant A.\} and Kuban, \{Deborah A.\} and Kuzel, \{Timothy M.\} and Lele, \{Subodh M.\} and Jeff Michalski and Pagliaro, \{Lance C.\} and Pal, \{Sumanta K.\} and Anthony Patterson and Plimack, \{Elizabeth R.\} and Pohar, \{Kamal S.\} and Porter, \{Michael P.\} and Richie, \{Jerome P.\} and Sexton, \{Wade J.\} and Shipley, \{William U.\} and Small, \{Eric J.\} and Spiess, \{Philippe E.\} and Trump, \{Donald L.\} and Geoffrey Wile and Wilson, \{Timothy G.\} and Mary Dwyer and Maria Ho",

year = "2013",

month = apr,

day = "1",

doi = "10.6004/jnccn.2013.0059",

language = "English",

volume = "11",

pages = "446--475",

journal = "Journal of the National Comprehensive Cancer Network : JNCCN",

issn = "1540-1405",

publisher = "Harborside Press",

number = "4",

}

Clark, PE, Agarwal, N, Biagioli, MC, Eisenberger, MA, Greenberg, RE, Herr, HW, Inman, BA, Kuban, DA, Kuzel, TM, Lele, SM, Michalski, J, Pagliaro, LC, Pal, SK, Patterson, A, Plimack, ER, Pohar, KS, Porter, MP, Richie, JP, Sexton, WJ, Shipley, WU, Small, EJ, Spiess, PE, Trump, DL, Wile, G, Wilson, TG, Dwyer, M & Ho, M 2013, 'Bladder cancer: Clinical practice guidelines in oncology', Journal of the National Comprehensive Cancer Network : JNCCN, vol. 11, no. 4, pp. 446-475. https://doi.org/10.6004/jnccn.2013.0059

TY - JOUR

T1 - Bladder cancer

T2 - Clinical practice guidelines in oncology

AU - Clark, Peter E.

AU - Agarwal, Neeraj

AU - Biagioli, Matthew C.

AU - Eisenberger, Mario A.

AU - Greenberg, Richard E.

AU - Herr, Harry W.

AU - Inman, Brant A.

AU - Kuban, Deborah A.

AU - Kuzel, Timothy M.

AU - Lele, Subodh M.

AU - Michalski, Jeff

AU - Pagliaro, Lance C.

AU - Pal, Sumanta K.

AU - Patterson, Anthony

AU - Plimack, Elizabeth R.

AU - Pohar, Kamal S.

AU - Porter, Michael P.

AU - Richie, Jerome P.

AU - Sexton, Wade J.

AU - Shipley, William U.

AU - Small, Eric J.

AU - Spiess, Philippe E.

AU - Trump, Donald L.

AU - Wile, Geoffrey

AU - Wilson, Timothy G.

AU - Dwyer, Mary

AU - Ho, Maria

PY - 2013/4/1

Y1 - 2013/4/1

N2 - Bladder cancer is the fourth most common cancer in the United States. Urothelial carcinoma that originates from the urinary bladder is the most common subtype. These NCCN Clinical Practice Guidelines in Oncology (NCCN Guidelines) provide recommendations on the diagnosis and management of non-muscle-invasive and muscle-invasive urothelial carcinoma of the bladder. This version of the guidelines provides extensive reorganization and updates on the principles of chemotherapy management.

AB - Bladder cancer is the fourth most common cancer in the United States. Urothelial carcinoma that originates from the urinary bladder is the most common subtype. These NCCN Clinical Practice Guidelines in Oncology (NCCN Guidelines) provide recommendations on the diagnosis and management of non-muscle-invasive and muscle-invasive urothelial carcinoma of the bladder. This version of the guidelines provides extensive reorganization and updates on the principles of chemotherapy management.

KW - Administration, Intravesical

KW - Algorithms

KW - Antineoplastic Combined Chemotherapy Protocols/therapeutic use

KW - Carcinoma/drug therapy

KW - Cystectomy/methods

KW - Female

KW - Humans

KW - Male

KW - Muscle Neoplasms/drug therapy

KW - Neoadjuvant Therapy/methods

KW - Neoplasm Invasiveness

KW - Neoplasm Staging/methods

KW - Organ Sparing Treatments/methods

KW - Urinary Bladder Neoplasms/drug therapy

KW - Urothelium/pathology

UR - https://www.scopus.com/pages/publications/84877961610

UR - https://www.webofscience.com/api/gateway?GWVersion=2&SrcApp=purepublist2023&SrcAuth=WosAPI&KeyUT=WOS:000317543800011&DestLinkType=FullRecord&DestApp=WOS

U2 - 10.6004/jnccn.2013.0059

DO - 10.6004/jnccn.2013.0059

M3 - Article

C2 - 23584347

SN - 1540-1405

VL - 11

SP - 446

EP - 475

JO - Journal of the National Comprehensive Cancer Network : JNCCN

JF - Journal of the National Comprehensive Cancer Network : JNCCN

IS - 4

ER -

Bladder cancer: Clinical practice guidelines in oncology

Abstract

UN SDGs

Keywords

Access to Document

Other files and links

Fingerprint

Cite this